Lucia Mazzolai

Publications | Mémoires et thèses

La recherche avancée est accessible via Serval

Les publications peuvent être gérées en accédant à Serval via MyUnil


362 publications

... | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | 2005 | 2004 | 2003 | 2002 | 2001 | 2000 | 1999 | 1998 | 1997 | 1994 | 1992 |
2016
 
Les nouveaux anticoagulants oraux.
Alatri Adriano, Mazzolai Lucia, 2016. La Gazette Médicale - info@gériatrie 6 pp. 15-17.
[serval:BIB_B88E94274ACC]
 
Myocardial infarction after ultrasoundguided foam sclerotherapy for varicose veins--a case report and review of the literature of a rare but serious adverse event.
Engelberger R.P., Ney B., Clair M., Dabiri A., Alatri A., Mazzolai L., Kern P., 2016. Vasa. Zeitschrift Für Gefässkrankheiten, 45 (3) pp. 255-258. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_27F916684E95]
 
Prevalence and risk factors for venous thromboembolic complications in the Swiss Inflammatory Bowel Disease Cohort.
Alatri A., Schoepfer A., Fournier N., Engelberger R.P., Safroneeva E., Vavricka S., Biedermann L., Calanca L., Mazzolai L., Swiss IBD Cohort Study Group, 2016. Scandinavian Journal of Gastroenterology, 51 (10) pp. 1200-1205. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_C1105D8E5054]
2015
 
Venous thromboembolism in patients with glioblastoma multiforme: Findings of the RIETE registry.
Portillo J., de la Rocha I.V., Font L., Braester A., Madridano O., Peromingo J.A., Apollonio A., Pagán B., Bascuñana J., Monreal M. et al., 2015/12. Thrombosis research, 136 (6) pp. 1199-1203. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_FACFF5457A1C]
Platelet Count and Major Bleeding in Patients Receiving Vitamin K Antagonists for Acute Venous Thromboembolism, Findings From Real World Clinical Practice.
Giorgi-Pierfranceschi M., Di Micco P., Cattabiani C., Guida A., Pagán B., Morales M.del V., Salgado E., Suriñach J.M., Tolosa C., Monreal M. et al., 2015/11. Medicine, 94 (47) pp. e1915. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_4BCDB161AA2A]
 
A RIETE registry analysis of recurrent thromboembolism and hemorrhage in patients with catheter-related thrombosis.
Baumann Kreuziger L., Cote L., Verhamme P., Greenberg S., Caprini J., Muñoz F.J., Valle R., Monreal Bosch M., RIETE Investigators, 2015/07. Journal of vascular surgery. Venous and lymphatic disorders, 3 (3) pp. 243-50.e1.
[DOI][Pmid][serval:BIB_02E1A6174C1E]
 
Subsequent arterial ischemic events in patients receiving anticoagulant therapy for venous thromboembolism.
Madridano O., del Toro J., Lorenzo A., Martín M., Gómez Cerezo J., Hernández L., Prandoni P., Monreal M., RIETE Investigators, 2015/04. Journal of vascular surgery. Venous and lymphatic disorders, 3 (2) pp. 135-41.e1.
[DOI][Pmid][serval:BIB_F620E5CE0C65]
 
Anomalies vasculaires: exemple du syndrome de Klippel-Trenaunay [Vascular anomalies].
Krieger Caroline Ade B, Roessingh Ade B, Depairon M., El Ezzi O., Hohlfeld J., Raffoul W., Qanadli S.D., Mazzolai L., 2015/02. Revue Médicale Suisse, 11 (460) pp. 357-361.
[Pmid][serval:BIB_FF262A87E67B]
 
A Prognostic Score to Identify Low-risk Outpatients with Acute Deep Vein Thrombosis in the Lower Limbs.
Trujillo-Santos J., Lozano F., Lorente M.A., Adarraga D., Hirmerova J., Del Toro J., Mazzolai L., Barillari G., Barrón M., Monreal M. et al., 2015. American Journal of Medicine, 128 (1) pp. 90.e9-90.e15. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_A3669171DD27]
 
Artériopathies non athéromateuses des membres inférieurs [Non atherosclerotic arterial disease of lower limbs].
Calanca L., Alatri A., Depairon M., Engelberger R.P., Mazzolai L., 2015. Revue Médicale Suisse, 11 (460) pp. 352, 354-352, 356.
[Pmid][serval:BIB_853C0E755E03]
Fatal Events in Cancer Patients Receiving Anticoagulant Therapy for Venous Thromboembolism.
Farge D., Trujillo-Santos J., Debourdeau P., Bura-Riviere A., Rodriguez-Beltrán E.M., Nieto J.A., Peris M.L., Zeltser D., Mazzolai L., Hij A. et al., 2015. Medicine, 94 (32) pp. e1235. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_53A318821B08]
Fluorine MR Imaging of Inflammation in Atherosclerotic Plaque in Vivo.
van Heeswijk R.B., Pellegrin M., Flögel U., Gonzales C., Aubert J.F., Mazzolai L., Schwitter J., Stuber M., 2015. Radiology, 275 (2) pp. 421-429. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_279183AA9412]
 
Interplay between connexin40 and nitric oxide signaling during hypertension.
Le Gal L., Alonso F., Mazzolai L., Meda P., Haefliger J.A., 2015. Hypertension, 65 (4) pp. 910-915. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_3C0F822A4B5C]
 
La maladie thromboembolique veineuse: cette "inconnue" [Venous thromboembolism: the "unknown"].
Mazzolai L., 2015. Revue Médicale Suisse, 11 (460) p. 335.
[Pmid][serval:BIB_EAC68F5B4D0D]
Long-Term Anticoagulant Therapy of Patients with Venous Thromboembolism. What Are the Practices?
Mahé I., Sterpu R., Bertoletti L., López-Jiménez L., Mellado Joan M., Trujillo-Santos J., Ballaz A., Hernández Blasco L.M., Marchena P.J., Monreal M. et al., 2015. Plos One, 10 (6) pp. e0128741. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_5235AEC57B36]
 
Pathologies vasculaires lymphatiques: apport de la lympho-fluoroscopie [Lymphatic vascular pathologies: contribution of lympho-fluoroscopy].
Tomson D., Lessert C., Luthi I., Mazzolai L., Depairon M., 2015. Revue Médicale Suisse, 11 (460) pp. 362-365.
[Pmid][serval:BIB_BEAF99E26AC5]
Prevalence and risk factors for thromboembolic complications in IBD patients
Schoepfer A., Alatri A., Fournier N., Safroneeva E., Calanca L., Mazzolai L., 2015., 10th Congress of ECCO-European Crohns & Colitis Organisation : Inflammatory bowel diseases. 18-21 February 2015, Barcelona, Spain pp. S178-S179 dans Journal of Crohn's & Colitis, Vol. 9 supl.1. Peer-reviewed.
[URN][WoS][serval:BIB_B7F2C3F1DB05]
 
Quelle prise en charge pour une suspicion de thrombose veineuse profonde des membres inférieurs [Suspicion of lower limb deep vein thrombosis: update on diagnosis and treatment].
Erdmann A., Alatri A., Engelberger R.P., Depairon M., Calanca L., Mazzolai L., 2015. Revue Médicale Suisse, 11 (460) pp. 337-341.
[Pmid][serval:BIB_21F1CA9CE78F]
The year in cardiology 2014: peripheral circulation.
Aboyans V., Brodmann M., De Carlo M., Clement D., Mazzolai L., van Bortel L., van Sambeek M.R., Vlachopoulos C., On Behalf the ESC Working Group of Peripheral Circulation, 2015. European Heart Journal, 36 (10) pp. 591-597. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_6E5EB9037103]
 
Traitement percutané de la thrombose veineuse profonde aiguë [Catheter-based treatment for acute deep vein thrombosis].
Engelberger R.P., Alatri A., Qanadli S.D., Calanca L., Mazzolai L., 2015. Revue Médicale Suisse, 11 (460) pp. 348-351. Peer-reviewed.
[Pmid][serval:BIB_1EA0F8BBB18F]
Ultra-high-resolution 3D imaging of atherosclerosis in mice with synchrotron differential phase contrast: a proof of concept study.
Bonanno G., Coppo S., Modregger P., Pellegrin M., Stuber A., Stampanoni M., Mazzolai L., Stuber M., van Heeswijk R.B., 2015. Scientific Reports, 5 p. 11980. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_05F33CDA64DE]
 
Venous thromboembolism in patients immobilised at home.
López-Reyes R., Nauffal D., Ballester M., Martín-Antorán J.M., de Sousa M.S., Riera-Mestre A., Ruiz-Ruiz J., Fernández-Capitán C., Uresandi F., Monreal M. et al., 2015. European Respiratory Journal, 45 (6) pp. 1728-1731. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_121694041792]
Voluntary Exercise Stabilizes Established Angiotensin II-Dependent Atherosclerosis in Mice through Systemic Anti-Inflammatory Effects.
Pellegrin M., Aubert J.F., Bouzourène K., Amstutz C., Mazzolai L., 2015. Plos One, 10 (11) pp. e0143536. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_E6947BD847EE]
2014
 
Traitement de l'ischémie critique chronique des membres inférieurs en 2014 [Treatment of critical lower limb ischemia].
Salomon du Mont L., Déglise S., Dubuis C., Saucy F., Doenz F., Calanca L., Qanadli S., Mazzolai L., Corpataux J M, 2014/10. Revue Médicale Suisse, 10 (447) pp. 1992-1996. Peer-reviewed.
[Pmid][serval:BIB_15119DDB0F41]
 
Maladies vasculaires rares [Rare vascular diseases].
Calanca L., Depairon M., Tribout B., Aebischer N., Burnier M., Fellmann F., Lazor R., Mazzolai L., 2014/02. Revue Médicale Suisse, 10 (416) pp. 347-50, 352.
[Pmid][serval:BIB_D39C18EC277E]
 
Clinical outcome in patients with venous thromboembolism receiving concomitant anticoagulant and antiplatelet therapy.
Tzoran I., Brenner B., Sakharov G., Trujillo-Santos J., Lorenzo A., Madridano O., López-Sáez J.B., Monreal M., RIETE investigators, 2014. European Journal of Internal Medicine, 25 (9) pp. 821-825. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_D6816FBC4487]
 
D-dimer levels and 90-day outcome in patients with acute pulmonary embolism with or without cancer.
Maestre A., Trujillo-Santos J., Visoná A., Lobo J.L., Grau E., Malý R., Duce R., Monreal M., RIETE Investigators, 2014. Thrombosis Research, 133 (3) pp. 384-389. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_3CB61DE2F6C6]
Experimental peripheral arterial disease: new insights into muscle glucose uptake, macrophage, and T-cell polarization during early and late stages.
Pellegrin M., Bouzourène K., Poitry-Yamate C., Mlynarik V., Feihl F., Aubert J.F., Gruetter R., Mazzolai L., 2014. Physiological Reports, 2 (2) pp. e00234. Peer-reviewed.
[URN][DOI][Pmid][serval:BIB_22CF686BDBFB]
 
Home versus in-hospital treatment of outpatients with acute deep venous thrombosis of the lower limbs.
Lozano F., Trujillo-Santos J., Barrón M., Gallego P., Babalis D., Santos M., Falgá C., Monreal M., RIETE Investigators, 2014. Journal of Vascular Surgery, 59 (5) pp. 1362-7.e1. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_AC5D4E40116A]
 
Influence of recent immobilization or surgery on mortality in cancer patients with venous thromboembolism.
Trujillo-Santos J., Gussoni G., Gadelha T., Sänchez Muñoz-Torrero J.F., Barron M., Lopez L., Ruiz-Ruiz J., Fernandez-Capitan C., Lorente M., Monreal M. et al., 2014. Thrombosis Research, 133 (Suppl 2) pp. S29-S34. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_2358F1E483ED]
Interaction between widening of diameter of abdominal aorta and cardiovascular risk factors and atherosclerosis burden.
Glauser F., Mazzolai L., Darioli R., Depairon M., 2014. Internal and Emergency Medicine, 9 (4) pp. 411-417.
[URN][DOI][WoS][Pmid][serval:BIB_862CAB2A99E9]
 
Outcomes in neurosurgical patients who develop venous thromboembolism: a review of the RIETE registry.
Cote L.P., Greenberg S., Caprini J.A., Stone J., Arcelus J.I., López-Jiménez L., Rosa V., Schellong S., Monreal M., RIETE Investigators, 2014. Clinical and Applied Thrombosis/hemostasis, 20 (8) pp. 772-778. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_ECE77A86D018]
 
Sex differences in patients receiving anticoagulant therapy for venous thromboembolism.
Blanco-Molina A., Enea I., Gadelha T., Tufano A., Bura-Riviere A., Di Micco P., Bounameaux H., González J., Villalta J., Monreal M. et al., 2014. Medicine, 93 (17) pp. 309-317. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_3E6684B47766]
2013
 
A clinical prognostic model for the identification of low-risk patients with acute symptomatic pulmonary embolism and active cancer.
den Exter P.L., Gómez V., Jiménez D., Trujillo-Santos J., Muriel A., Huisman M.V., Monreal M., Registro Informatizado de la Enfermedad TromboEmbólica (RIETE) Investigators, 2013. Chest, 143 (1) pp. 138-145.
[DOI][WoS][Pmid][serval:BIB_51871E808374]
Angiotensin II as an Inducer of Atherosclerosis: Evidence from Mouse Studies
Pellegrin M., Mazzolai L., 2013. Journal of Clinical and Experimental Cardiology, 1 (S1) p. 007.
[URN][DOI][serval:BIB_E6568726F216]
 
Anévrismes de l'artère poplitée: quelle prise en charge en 2013 ? [Popliteal artery aneurysms: management in 2013].
Dubuis C., Déglise S. , Saucy F., Holzer T., Calanca L., Mazzolai L., Doenz F., Qanadli S.D., Corpataux J.M., 2013. Revue Médicale Suisse, 9 (391) pp. 1299-1304.
[Pmid][serval:BIB_341FB5B91D38]
 
Deep vein thrombosis of the penis: an unusual but severe complication of prostatic abscess.
Calanca L., Alatri A., Schaller M.D., Sermier A., Mazzolai L., 2013. Vasa. Zeitschrift Für Gefässkrankheiten, 42 (3) pp. 214-217.
[DOI][WoS][Pmid][serval:BIB_4DEDE37A5B18]
 
Edoxaban versus warfarin for the treatment of symptomatic venous thromboembolism.
Hokusai-VTE Investigators, Büller H.R., Büller H.R., Décousus H., Grosso M.A., Mercuri M., Middeldorp S., Prins M.H., Raskob G.E., Schellong S.M. et al., 2013. New England Journal of Medicine, 369 (15) pp. 1406-1415.
[DOI][WoS][Pmid][serval:BIB_8B6930265D76]
 
Platelet count and outcome in patients with acute venous thromboembolism.
Di Micco P., Ruiz-Giménez N., Nieto J.A., Aujesky D., del Molino F., Valle R., Barrón M., Maestre A., Monreal M., RIETE investigators, 2013. Thrombosis and Haemostasis, 110 (5) pp. 1025-1034.
[DOI][WoS][Pmid][serval:BIB_15E813BB5B2E]
 
Quet anticoagulant pour quel patient [Which anticoagulant agent for which patient?].
Righini M., Mazzolai L., de Moerloose P., 2013. Revue Médicale Suisse, 9 (372) pp. 299-300.
[Pmid][serval:BIB_C38E04EE3235]
Reduction of connexin36 content by ICER-1 contributes to insulin-secreting cells apoptosis induced by oxidized LDL particles.
Haefliger J.A., Martin D., Favre D., Petremand Y., Mazzolai L., Abderrahmani A., Meda P., Waeber G., Allagnat F., 2013. PLOS One, 8 (1) pp. e55198.
[URN][DOI][WoS][Pmid][serval:BIB_70DABA808272]
 
Syndrome de l'artère poplitée piégée [Popliteal artery entrapment syndrome].
Calanca L., Glauser F., Alatri A., Mazzolai L., 2013. Revue Médicale Suisse, 9 (372) pp. 311-314.
[Pmid][serval:BIB_77800E3F2AF6]
 
The Swiss cohort of elderly patients with venous thromboembolism (SWITCO65+): rationale and methodology.
Méan M., Righini M., Jaeger K., Beer H.J., Frauchiger B., Osterwalder J., Kucher N., Lämmle B., Cornuz J., Angelillo-Scherrer A. et al., 2013. Journal of Thrombosis and Thrombolysis, 36 (4) pp. 475-483.
[DOI][WoS][Pmid][serval:BIB_2A7B7863EF1F]
2012
 
Assessment of coronary vasoreactivity by multidetector computed tomography: feasibility study with rubidium-82 cardiac positron emission tomography.
Dunet V., Qanadli S.D., Allenbach G., Dabiri A., Mazzolai L., Waeber B., Feihl F., Prior J.O., 2012. Circulation journal : official journal of the Japanese Circulation Society, 76 (1) pp. 160-167. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_3B936E95E0BA]
 
Changes in Aortic Pulse Wave Velocity in Hypertensive Postmenopausal Women: Comparison Between a Calcium Channel Blocker vs Angiotensin Receptor Blocker Regimen.
Hayoz D., Zappe D.H., Meyer M.A., Baek I., Kandra A., Joly M.P., Mazzolai L., Haesler E., Periard D., 2012. Journal of Clinical Hypertension, 14 (11) pp. 773-778.
[DOI][WoS][Pmid][serval:BIB_BEC52BA8A0F9]
 
Desensitization of thermal hyperemia in the skin is reproducible.
Frantz J., Engelberger R.P., Liaudet L., Mazzolai L., Waeber B., Feihl F., 2012. Microcirculation, 19 (1) pp. 78-85. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_005E650DA803]
Fluorine-19 Magnetic Resonance Imaging in a Mouse Model of Atherosclerosis. Subject: Cardiovascular MRI
van Heeswijk R., Pellegrin M., Mazzolai L., Flögel U., Schwitter J., Stuber M., 2012. p. 3945 dans ISMRM 2012, 20th Annual Meeting and Exhibition of the International Society for Magnetic Resonance in Medicine, SMRT 21st Annual Meeting of the Section for Magnetic Resonance Technologists, Proceedings of the International Society for Magnetic Resonance in Medicine.
[URN][serval:BIB_752087E4D3F1]
 
Intravital microscopy reveals endothelial dysfunction in resistance arterioles in Angiotensin II-induced hypertension.
Schäfer S.C., Pellegrin M., Wyss C., Aubert J.F., Nussberger J., Hayoz D., Lehr H.A., Mazzolai L., 2012. Hypertension Research, 35 (8) pp. 855-861.
[DOI][WoS][Pmid][serval:BIB_4C9B8BB08C3D]
Mesure de l'index bras-cheville pour le dépistage des artériopathies oblitérantes périphériques
Monti M., Mazzolai L., 2012. Swiss Medical Forum, 12 (27-28) pp. 549-553. Peer-reviewed.
[URN][serval:BIB_03DF9558AB80]
 
Prise en charge du syndrome post-thrombotique [Management of post-thrombotic syndrome].
Alatri A., Mazzolai L., 2012. Praxis, 101 (13) pp. 843-848.
[DOI][Pmid][serval:BIB_54A705FE0D5E]
 
Prospective comparison of clinical prognostic scores in elderly patients with pulmonary embolism.
Zwierzina D., Limacher A., Méan M., Righini M., Jaeger K., Beer H.J., Frauchiger B., Osterwalder J., Kucher N., Matter C.M. et al., 2012. Journal of Thrombosis and Haemostasis, 10 (11) pp. 2270-2276. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_F6088F1A4521]
 
Prévention de la maladie veineuse chronique: quels conseils donner à nos patients [Prevention of chronic venous disease: which advice for our patients?].
Glauser F., Codreanu A., Tribout B., Mazzolai L., Depairon M., 2012. Revue Médicale Suisse, 8 (327) pp. 306-310.
[Pmid][serval:BIB_F3197C36B386]
 
Prévention des troubles lymphatiques et de leurs complications [Lymphatic disorders and prevention of their complications].
Tomson D., Lessert C., Klumbach D., Mazzolai L., Depairon M., 2012. Revue Médicale Suisse, 8 (327) pp. 315-319.
[Pmid][serval:BIB_31FA91698477]
 
Prévention du syndrome post-thrombotique [Prevention of post-thrombotic syndrome].
Alatri A., Calanca L., Tomson D., Mazzolai L., 2012. Revue Médicale Suisse, 8 (327) pp. 311-314.
[Pmid][serval:BIB_7A2D7403CCA9]
 
Qualité de vie après traitement de l'insuffisance veineuse superficielle primaire. [Quality of life in patients traited for primary superficial venous insufficiency].
Marques-Vidal P., Imsand D., Kayoumi A., Kern Ph., Mazzolai L., Depairon M., 2012. Praxis, 101 (10) pp. 645-650.
[DOI][Pmid][serval:BIB_D6AF12DA16F7]
 
Reduction of small infrarenal abdominal aortic aneurysm expansion rate by statins.
Periard D., Guessous I., Mazzolai L., Haesler E., Monney P., Hayoz D., 2012. VASA, 41 (1) pp. 35-42. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_0F961313B3B4]
 
Rééducation vasculaire du patient artériopathe [Vascular rehabilitation of patients suffering from peripheral arterial disease].
Calanca L., Alatri A., Junod N., Theurillat C., Mazzolai L., 2012. Revue Médicale Suisse, 8 (327) pp. 302-305.
[Pmid][serval:BIB_F8421AFF19CB]
 
Suivi angiologique des patients artériopathes après geste de revascularisation [Vascular follow up in patients suffering peripheral arterial disease and undergoing revascularization].
Codreanu A., Calanca L., Glauser F., Corpataux J.M., Qanadli S., Mazzolai L., Depairon M., 2012. Revue Médicale Suisse, 8 (327) pp. 324-327. Peer-reviewed.
[Pmid][serval:BIB_CB441423C594]
 
Vorapaxar in the secondary prevention of atherothrombotic events.
Morrow D.A., Braunwald E., Bonaca M.P., Ameriso S.F., Dalby A.J., Fish M.P., Fox K.A., Lipka L.J., Liu X., Nicolau J.C. et al., 2012. New England Journal of Medicine, 366 (15) pp. 1404-1413.
[DOI][WoS][Pmid][serval:BIB_FACCD3108A83]
X-ray phase contrast grating inferometry for atherosclerosis imaging in mice. Session XII: New Acquisition Techniques and Processing Methods (3). Abstract
van Heeswijk R., Modregger P., Coppo S., Bonanno G., Pellegrin M., Aubert J.F., Stampanoni M., Mazzolai L., Stuber M., 2012. dans MRA 2012, 24th Annual International Conference of the Magnetic Resonance Angiography Working Group.
[URN][serval:BIB_B28B3A355927]
2011
Sclérothérapie : explications pour le patient
Centre Hospitalier Universitaire Vaudois. Service d'Angiologie , Policlinique médicale universitaire (Lausanne) , 2011/11. 2.
[URN][serval:BIB_1720A4827602]
Traitement des varices : laser endoveineux : votre angiologue vous informe
Centre Hospitalier Universitaire Vaudois. Service d'Angiologie , 2011/11. 6.
[URN][serval:BIB_DAF52F45C393]
Traitement des varices : phlébectomie : votre angiologue vous informe
Centre Hospitalier Universitaire Vaudois. Service d'Angiologie , 2011/11. 6.
[URN][serval:BIB_5088475811C9]
Traitement des varices : sclérothérapie échoguidée : votre angiologue vous informe
Centre Hospitalier Universitaire Vaudois. Service d'Angiologie , 2011/11. 6.
[URN][serval:BIB_0DE33E908A03]
Traitement et prophylaxie de la Maladie ThromboEmbolique Veineuse (MTEV)
Centre hospitalier universitaire vaudois, Policlinique médicale universitaire (Lausanne) , 2011/05. 2 p..
[URN][serval:BIB_EFE579EC6162]
Mise en place percutanée de filtres dans la veine cave inférieure en prévention de l'embolie pulmonaire : recommandations
Mazzolai L., Qanadli S., 2011/04. 7 p..
[URN][serval:BIB_D67D89778302]
 
A double-blind, randomized study comparing pure chromated glycerin with chromated glycerin with 1% lidocaine and epinephrine for sclerotherapy of telangiectasias and reticular veins.
Kern P., Ramelet A.A., Wutschert R., Mazzolai L., 2011. Dermatologic Surgery, 37 (11) pp. 1590-1594.
[DOI][WoS][Pmid][serval:BIB_0A6DA5E7EE1D]
Atherosclerosis in ApoE-deficient mice progresses independently of the NLRP3 inflammasome.
Menu P., Pellegrin M., Aubert J.F., Bouzourene K., Tardivel A., Mazzolai L., Tschopp J., 2011. Cell Death and Disease, 2 pp. e137.
[URN][DOI][WoS][Pmid][serval:BIB_6DB36CC14A46]
 
Characterization of Human Late Outgrowth Endothelial Progenitor-Derived Cells under Various Flow Conditions.
Mazzolai L., Bouzourene K., Hayoz D., Dignat-George F., Liu J.W., Bounameaux H., Dunoyer-Geindre S., Kruithof E.K., 2011. Journal of Vascular Research, 48 (5) pp. 443-451.
[DOI][WoS][Pmid][serval:BIB_81B8D95477AA]
 
Comparison of the diagnostic performance of the original and modified Wells score in inpatients and outpatients with suspected deep vein thrombosis.
Engelberger R.P., Aujesky D., Calanca L., Staeger P., Hugli O., Mazzolai L., 2011. Thrombosis Research, 127 (6) pp. 535-539.
[DOI][WoS][Pmid][serval:BIB_7A852CC879D3]
Consequences of the multipatient use of a single-patient capillary blood sampling device (CBSD)
Staeger P., Ninane F., Mazzolai L., Moradpour D., Wasserfallen J., Masserey E., Senn L., Zanetti G., 2011. pp. P92 dans ICPIC 2011, 1st International Conference on Prevention and Infection Control, BMC Proceedings.
[URN][DOI][serval:BIB_050F348729F8]
 
Gewisse Patienten profitieren von einem Selfmanagement der oralen Antikoagulation.
Nanchen David, Mazzolai Lucia, Peytremann-Bridevaux Isabelle, 2011. Praxis, 100 (16) pp. 983-984.
[DOI][Pmid][serval:BIB_B9994EC179B5]
L'artériopathie oblitérante des membres inférieurs : Les exercices apportent les bénéfices, les médicaments y contribuent
Calanca L., Mazzolai L., 2011. CardioVasc 2 pp. 34-37.
[URN][serval:BIB_4EA64F1D6CF5]
La Société suisse d'Angiologie fête ses 50 ans : regard rétrospectif sur les avancées clés de la médecine vasculaire et perspectives
Amann-Vesti B., Baumgartner I., Bounameaux H., Canova C., Frauchiger B., Haesler E., Hayoz D., Husmann M., Jäger K., Mazzolai L. et al., 2011. Swiss Medical Forum = Forum Médical Suisse, 11 (48) pp. 889-890.
[URN][serval:BIB_B8383385D149]
 
Long-term swimming exercise does not modulate the Akt-dependent endothelial nitric oxide synthase phosphorylation in healthy mice.
Pellegrin M., Miguet-Alfonsi C., Berthelot A., Mazzolai L., Laurant P., 2011. Canadian Journal of Physiology and Pharmacology, 89 (1) pp. 72-76.
[DOI][WoS][Pmid][serval:BIB_758A7F58ACA0]
 
Physiothérapie et cancer du sein
Tomson D., Aeschlimann B., Lessert C., Larcinese A., Depairon M., Mazzolai L., 2011. Physioactive, 47 (1) pp. 7-12.
[serval:BIB_44A944A7C48E]
 
Pourquoi lire les articles de ce numéro d'angiologie et hémostase [Why read the articles in this issue of Angiology and Hemostasis].
de Moerloose P., Mazzolai L., Bounameaux H., 2011. Revue Médicale Suisse, 7 (281) pp. 331-332.
[Pmid][serval:BIB_31DB8E45270B]
 
Prise en charge du syndrome post-thrombotique [Management of postthrombotic syndrome].
Mazzolai L., 2011. Revue Médicale Suisse, 7 (294) p. 1040.
[Pmid][serval:BIB_843B37AC88C8]
 
Risque thrombotique sous procréation médicalement assistée [Thrombotic risk in assisted reproductive technology].
Alatri A., Tribout B., Gencer B., Calanca L., Mazzolai L., 2011. Revue Médicale Suisse, 7 (281) pp. 357-360.
[Pmid][serval:BIB_9711B1BCC641]
 
The risk of subsequent cancer and arterial cardiovascular events in patients with superficial vein thrombosis in the legs.
Prandoni P., Casiglia E., Tikhonoff V., Leizorovicz A., Decousus H., Calisto Investigators, 2011. Blood, 118 (17) pp. 4719-4722.
[DOI][WoS][Pmid][serval:BIB_643A99A1DD84]
 
Thrombose veineuse superficielle: quelles nouveautés dans la prise en charge [Superficial vein thrombosis: what's new in the management?].
Gencer B., Tribout B., Alatri A., Mazzolai L., Calanca L., 2011. Revue Médicale Suisse, 7 (314) pp. 2098-2101.
[Pmid][serval:BIB_E21B08E2B5E0]
2010
An angiotensin II- and NF-kappaB-dependent mechanism increases connexin 43 in murine arteries targeted by renin-dependent hypertension.
Alonso F., Krattinger N., Mazzolai L., Simon A., Waeber G., Meda P., Haefliger J.A., 2010. Cardiovascular Research, 87 (1) pp. 166-176.
[URN][DOI][WoS][Pmid][serval:BIB_C5BA88DA7FAC]
 
Changes in Aortic Pulse Wave Velocity in Hypertension Post-Menopausal Women: Comparison Between Calcium Channel Blocker (CCB) Vs Angiotensin Receptor Blocker (ARB) Regimen
Hayoz D., Zappe D.H., Baek I.Y., Kandra A., Rey-Meier M.A., Joly M.P., Haesler E., Mazzolai L., Periard D., 2010. pp. E390 dans 20th Annual Meeting of the European-Society-of-Hypertension, Journal of Hypertension. Peer-reviewed.
[WoS][serval:BIB_D2E5E1A9348F]
Evidence for a role of sphingosine-1 phosphate in cardiovascular remodelling in Fabry disease.
Brakch N., Dormond O., Bekri S., Golshayan D., Correvon M., Mazzolai L., Steinmann B., Barbey F., 2010. European Heart Journal, 31 (1) pp. 67-76.
[URN][DOI][WoS][Pmid][serval:BIB_0D07AF028847]
 
Ex vivo Pulsatile Perfusion of Human Saphenous Veins Induces Intimal Hyperplasia and Increased Levels of the Plasminogen Activator Inhibitor 1.
Saucy F., Probst H., Alonso F., Bérard X., Déglise S., Dunoyer-Geindre S., Mazzolai L., Kruithof E., Haefliger J.A., Corpataux J.M., 2010. European Surgical Research, 45 (1) pp. 50-59.
[DOI][WoS][Pmid][serval:BIB_B5181A246808]
 
Exercice physique et artériopathie oblitérante des membres inférieurs [Physical activity and peripheral arterial obstructive disease]
Calanca L., Pellegrin M., Mazzolai L., 2010. Revue Médicale Suisse, 6 (235) pp. 278-281.
[Pmid][serval:BIB_81F0AD1412D8]
 
Fondaparinux for the treatment of superficial-vein thrombosis in the legs.
Decousus H., Prandoni P., Mismetti P., Bauersachs R.M., Boda Z., Brenner B., Laporte S., Matyas L., Middeldorp S., Sokurenko G. et al., 2010. New England Journal of Medicine, 363 (13) pp. 1222-1232.
[DOI][WoS][Pmid][serval:BIB_CF5B25B979C9]
 
L'autogestion de l'anticoagulation orale: un avantage pour certains patients: revue Cochrane pour le praticien
Nanchen David, Mazzolai Lucia, Peytremann Bridevaux Isabelle, 2010. Revue médicale suisse, 6 (273) p. 2320.
[serval:BIB_5238914EFC6D]
Lack of prophylaxis before the onset of acute venous thromboembolism among hospitalized cancer patients: the SWIss Venous ThromboEmbolism Registry (SWIVTER).
Kucher N., Spirk D., Baumgartner I., Mazzolai L., Korte W., Nobel D., Banyai M., Bounameaux H., 2010. Annals of Oncology, 21 (5) pp. 931-935.
[URN][DOI][WoS][Pmid][serval:BIB_76045116253C]
 
Neuroendocrine characterization and anorexigenic effects of telmisartan in diet- and glitazone-induced weight gain.
Aubert Gregory, Burnier Michel, Dulloo Abdul, Perregaux Christine, Mazzolai Lucia, Pralong Francois, Zanchi Anne, 2010. Metabolism: Clinical and Experimental, 59 (1) pp. 25-32. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_30E656105251]
 
Nouvelle édition : accès simple et rapide aux recommandations concernant la prophylaxie et le traitement de la maladie thromboembolique veineuse
Albisetti M., Asmis L., Baumgartner I., Birrer S., Bounameaux H., Husmann M., Mazzolai L., Kucher N., Spirk D., Windecker S. et al., 2010. Swiss Medical Forum = Forum Médical Suisse, A10 (15) p. 277.
[serval:BIB_8328E8D3D5E9]
 
Oral rivaroxaban for symptomatic venous thromboembolism.
EINSTEIN Investigators, Bauersachs R., Bauersachs R., Berkowitz S.D., Brenner B., Buller H.R., Decousus H., Gallus A.S., Lensing A.W., Misselwitz F. et al., 2010. New England Journal of Medicine, 363 (26) pp. 2499-2510.
[DOI][Pmid][serval:BIB_F8DB408865A2]
 
The prediction of cardiovascular events is improved by combination of Framingham risk score and subclinical atherosclerosis imaging
Depairon Michèle, Stauffer Iris, Berthoud Maud, Mazzolai Lucia, Marques-Vidal Pedro Manuel, Darioli Roger, 2010. pp. 810-811 dans ESC Congress 2010, 28 August-1 September 2010, Stockholm, European Heart Journal.
[WoS][serval:BIB_31F63E4937E5]
 
Traitement de l'insuffisance veineuse superficielle primaire en pratique quotidienne : évaluation comparative du laser endoveineux versus traitement chirurgical conventionnel
Imsand D., Ducrey N., Kayoumi A., Kern P., Marques-Vidal P., Mazzolai L., Depairon M., 2010. Phlébologie, 63 (1) pp. 17-22. Peer-reviewed.
[serval:BIB_EB93EC8A8073]
2009
 
Angiologie: l'ensemble des parties peut faire un tout [Angiography: need for a multidisciplinary approach]
Mazzolai L., Bounameaux H., de Moerloose P., Hayoz D., 2009. Revue Médicale Suisse, 5 (189) pp. 291-292.
[Pmid][serval:BIB_179A15E288BE]
 
Dysfonction endothéliale et risque cardiovasculaire : l'exercice protège la fonction endothéliale et prévient la maladie cardiovasculaire [Endothelial dysfunction and cardiovascular risk : xercise protects endothelial function and prevents cardiovascular disease]
Pellegrin M., Mazzolai L., Berthelot A., Laurant P., 2009. Science and Sports, 24 (2) pp. 63-73. Peer-reviewed.
[DOI][WoS][serval:BIB_4794935AB94B]
 
Epidemiologie der chronisch venösen Insuffizienz--Schweizer Befragung liefert überraschende Ergebnisse [Epidemiology of chronic venous insufficiency--Swiss survey with surprising results]
Traber J., Mazzolai L., Läuchli S., 2009. Praxis, 98 (14) pp. 749-755.
[DOI][Pmid][serval:BIB_ED3E5B2A74F8]
 
Inferior vena cava agenesis: Association with bilateral lower-limb deep vein thrombosis in young males.
Guanella R., Glauser F., Bounameaux H., Mazzolai L., 2009. Thrombosis and Haemostasis, 102 (4) pp. 795-798. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_D65DE0F3B14D]
 
L'ergotisme
Mazzolai L., 2009..
[serval:BIB_8C9C895DC87D]
 
Long-term exercise stabilizes atherosclerotic plaque in apolipoprotein-E deficient mice
Pellegrin M., Miguet-Alfonsi C., Bouzourene K., Aubert J.F., Deckert V., Berthelot A., Mazzolai L., Mach F., Haefliger J.A., Alonso F. et al., 2009. Medicine and Science in Sports and Exercise, 41 (12) pp. 2128-2135. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_97658A3B098A]
 
Lower limb high arterial flow induced by tenofovir and emtricitabine treatment.
Periard D., Yerly P., Hayoz D., Mazzolai L., Widmeier A., Cavassini M., 2009. Antiviral therapy, 14 (6) pp. 865-867. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_CE4389E51B7D]
 
Mieux vivre le lymphoedème: le présent et l'avenir [To live with lymphoedema: present and future]
Depairon M., Pittet L., Paillex R., Klumbach D., Mazzolai L., 2009. Revue Médicale Suisse, 5 (189) pp. 299-302.
[Pmid][serval:BIB_F34860AEE1CF]
Outpatient treatment of pulmonary embolism.
Aujesky D., Mazzolai L., Hugli O., Perrier A., 2009. Swiss Medical Weekly, 139 (47-48) pp. 685-690.
[URN][DOI][WoS][Pmid][serval:BIB_256EBDF2578D]
 
Problèmes dus aux fistules d'hémodialyse: un réseau régional de prise en charge [Problems related to haemodialysis vascular accesses: a regional network of care]
Imsand D., Teta D., Saucy F., Doenz F., Qanadli S.D., Corpataux J.M., Burnier M., Mazzolai L., Haesler E., 2009. Revue Médicale Suisse, 5 (189) pp. 294-298.
[Pmid][serval:BIB_FDBC1FF84752]
 
Prévention et traitement à long terme de l'insuffisance veineuse chronique
Läuchli S., Mazzolai L., Träber J., 2009. Swiss Medical Forum = Forum Médical Suisse, 9 (38) pp. 664-668.
[serval:BIB_933C3AE64960]
 
Schweizer Konsensus zur Therapie mit Thrombozyten-Funktionshemmern in der Angiologie
Jäger K.A., Amann-Vesti B.R., Banyai M., Baumgartner I., Birrer M., Bounameaux H., Canova C.R., Frank U., Frauchiger B., Gallino A. et al., 2009. Swiss Medical Forum = Forum Médical Suisse, 9 (39) pp. 690-693.
[serval:BIB_9567B90C81DA]
 
Swimming prevents vulnerable atherosclerotic plaque development in hypertensive 2-kidney, 1-clip mice by modulating angiotensin II type 1 receptor expression independently from hemodynamic changes.
Pellegrin M., Alonso F., Aubert J.F., Bouzourene K., Braunersreuther V., Mach F., Haefliger J.A., Hayoz D., Berthelot A., Nussberger J. et al., 2009. Hypertension, 53 (5) pp. 782-789.
[DOI][WoS][Pmid][serval:BIB_484A9AAB7393]
 
The role of CT phlebography in the assessment of the vena cava filter
Al Qahtani S., Juette A., Chlapoutaki C., Mazzolai L., Qanadli S.D., 2009. dans USSMV 2009, 10th Annual Meeting of the Union of Vascular Societies of Switzerland.
[serval:BIB_92A1DC349CC7]
 
Traitement et prévention de la maladie thromboembolique veineuse: quoi de neuf ? [Treatment and prevention of venous thromboembolic disease: what's new?]
Rey M.A., Bron C., Haesler E., Mazzolai L., 2009. Revue Médicale Suisse, 5 (189) pp. 316-320.
[Pmid][serval:BIB_7A6242851382]
 
Traitement médicamenteux de l'artériopathie périphérique [Medical therapy in peripheral arterial occlusive disease]
Périard D., Hayoz D., Mazzolai L., 2009. Revue Médicale Suisse, 5 (189) pp. 312-315.
[Pmid][serval:BIB_C7BB254942E7]
VenaVita : le programme pratique de 5 minutes pour la santé et la beauté de vos jambes avec Vreni Schneider
Läuchli S., Traber J., Mazzolai L., Schlegel C., Schär T., Leg Health Center Switzerland, 2009..
[URN][serval:BIB_5B90BFC4000F]
2008
 
Clinical predictors of prophylaxis use prior to the onset of acute venous thromboembolism in hospitalized patients SWIss Venous ThromboEmbolism Registry (SWIVTER).
Kucher N., Spirk D., Kalka C., Mazzolai L., Nobel D., Banyai M., Frauchiger B., Bounameaux H., 2008. Journal of Thrombosis and Haemostasis, 6 (12) pp. 2082-7.
[DOI][WoS][Pmid][serval:BIB_726D984FF8DE]
 
Education thérapeutique du patient et illettrisme en Suisse
de Moerloose P., Mazzolai L., Bounameaux H., 2008. Revue Médicale Suisse, 4 (143) pp. 323-324.
[serval:BIB_37425CC4D14B]
 
Increased Expression of Renal Cyclooxygenase-2 and Neuronal Nitric Oxide Synthase in Hypertensive Cx40-Deficient Mice.
Krattinger N., Alonso F., Capponi A., Mazzolai L., Nicod P., Meda P., Haefliger J.A., 2008. Journal of Vascular Research, 46 (3) pp. 188-198.
[DOI][WoS][Pmid][serval:BIB_B94A14FEFFB5]
 
La thrombose veineuse superficielle : commentaire [Superficial vein thrombosis : commentary]
Depairon M., Mazzolai L., Gillet J.L., 2008. Angéiologie, 60 (4) pp. 41-47.
[serval:BIB_D6C0C5277205]
 
Les traitements cardiovasculaires hybrides: la prise en charge multidisciplinaire de l'avenir [Hybrid cardiovascular treatments: multidisciplinary management of the future]
Vogt P., Mazzolai L., Sekarski N., von Segesser L.K., 2008. Revue Médicale Suisse, 4 (150) p. 787.
[Pmid][serval:BIB_11D440B10643]
 
Long-term swimming exercise promotes atherosclerotic plaque stability in apolipoprotein-E deficient mice (ApoE(-/-)): role of Akt-mediated endothelial nitric oxide synthase (eNOS) phosphorylation pathway
Pellegrin M, Miguet-Alfonsi C, Bouzourene K, Aubert JF, Berthelot A, Mazzolai L, Laurant P, 2008. European Journal of Clinical Investigation, 38 pp. 29-29. Peer-reviewed.
[WoS][serval:BIB_F09A38B524D4]
 
Maladies vasculaires: quels dépistages au cabinet du praticien [Vascular diseases: what screening could be done in the office?]
Fumeaux J., Depairon M., Mazzolai L., 2008. Revue Médicale Suisse, 4 (143) pp. 336-8, 340-2.
[Pmid][serval:BIB_476EECE8DAFC]
 
Randomized controlled trial of peripherally inserted central catheters vs. peripheral catheters for middle duration in-hospital intravenous therapy.
Periard D., Monney P., Waeber G., Zurkinden C., Mazzolai L., Hayoz D., Doenz F., Zanetti G., Wasserfallen J.B., Denys A., 2008. Journal of Thrombosis and Haemostasis, 6 (8) pp. 1281-1288. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_73F5B552EF34]
 
Renin inhibition by aliskiren prevents atherosclerosis progression: comparison with irbesartan, atenolol, and amlodipine.
Nussberger J., Aubert J.F., Bouzourene K., Pellegrin M., Hayoz D., Mazzolai L., 2008. Hypertension, 51 (5) pp. 1306-1311.
[DOI][WoS][Pmid][serval:BIB_525DCE576106]
2007
 
Hereditary thrombophilia and venous thromboembolism: critical evaluation of the clinical implications of screening
Mazzolai L., Duchosal M. A., 2007/10. European Journal of Vascular and Endovascular Surgery, 34 (4) pp. 483-488.
[DOI][WoS][Pmid][serval:BIB_3CC34FD5C6E9]
 
Connexin40 regulates renin production and blood pressure.
Krattinger N., Capponi A., Mazzolai L., Aubert J.F., Caille D., Nicod P., Waeber G., Meda P., Haefliger J.A., 2007. Kidney international, 72 (7) pp. 814-22. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_4029A2D5D3FA]
 
Endothelial function, mechanical stress and atherosclerosis.
Hayoz D., Mazzolai L., 2007. Advances in Cardiology, 44 pp. 62-75.
[DOI][WoS][Pmid][serval:BIB_733D9457A849]
 
Un accès simple et rapide aux recommangations concernant la prophylaxie et le traitement de la maladie thromboembolique veineuse
Mazzolai Lucia, 2007. Swiss Medical Forum = Forum Médical Suisse, 7 (42) p. 864.
[serval:BIB_C3D81275E7AE]
2006
 
Fondaparinux is a safe alternative in case of heparin intolerance during pregnancy
Mazzolai L., Hohlfeld P., Spertini F., Hayoz D., Schapira M., Duchosal M. A., 2006/09. Blood, 108 (5) pp. 1569-1570.
[DOI][WoS][Pmid][serval:BIB_E03D2BD15F9F]
 
The renin-angiotensin system and atherosclerosis.
Mazzolai L., Hayoz D., 2006/04. Current Hypertension Reports, 8 (1) pp. 47-53. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_FB73F3CDDEF2]
 
La thrombose veineuse profonde: epidemiologie, facteurs de risque et evolution naturelle. [Deep vein thrombosis: epidemiology, risk factors and natural history]
Coiteux I., Mazzolai L., 2006/03. Schweizerische Rundschau fur Medizin Praxis, 95 (12) pp. 455-9.
[Pmid][serval:BIB_581781A8B1E9]
 
Etablir le pronostic de l'embolie pulmonaire: est-ce important pour la prise en charge? [The prognosis of pulmonary embolism: are there practical implications for patient management?]
Aujesky D., Mazzolai L., Perrier A., 2006/01. Revue Médicale Suisse, 2 (50) pp. 281-4.
[Pmid][serval:BIB_DA8C168311AC]
 
La thrombose veineuse profonde chez l'adolescent [Venous thromboembolic disease in adolescents]
Periard D., Haesler E., Ducrey N., von der Weid N., Mazzolai L., 2006. Revue médicale suisse, 2 (51) pp. 318-22.
[Pmid][serval:BIB_8199A9983DAF]
 
Severe hyperlipidemia causes impaired renin-angiotensin system function in apolipoprotein E deficient mice.
Mazzolai L., Korber M., Bouzourene K., Aubert J.F., Nussberger J., Stamenkovic I., Hayoz D., 2006. Atherosclerosis, 186 (1) pp. 86-91. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_5BB2BD57F6AA]
2005
 
Expérience clinique initiale avec un filtre cave Nitinol récupérable (Optease)
Juette L., Mazzolai L., Doenz F., Denys A., Schnyder P., Qanadli S.D., 2005/10. dans JFR 53e Journées Françaises de Radiologie, Journal de Radiologie.
[serval:BIB_99592FF1B9CC]
 
The renin-angiotensin-aldosterone-system
Mazzolai L., Nussberger J., 2005. pp. 143-156 dans Battegay E., Lip G., Bakris G. (eds.) Hypertension : principles and practice chap. 9, Taylor & Francis.
[serval:BIB_BC45E51E08E0]
2004
 
Thrombin stimulates human endothelial arginase enzymatic activity via RhoA/ROCK pathway: implications for atherosclerotic endothelial dysfunction
Ming X. F., Barandier C., Viswambharan H., Kwak B. R., Mach F., Mazzolai L., Hayoz D., Ruffieux J., Rusconi S., Montani J. P. et al., 2004/12. Circulation, 110 (24) pp. 3708-14.
[DOI][WoS][Pmid][serval:BIB_9EDC1ED4DD11]
 
Comparison of morphological and functional alterations of human saphenous veins after seven and fourteen days of ex vivo perfusion
Paroz A., Probst H., Saucy F., Mazzolai L., Rizzo E., Ris H. B., Corpataux J. M., 2004/10. European Surgical Research, 36 (5) pp. 274-81.
[DOI][WoS][Pmid][serval:BIB_B8E8112F6233]
 
Gelsolin superfamily proteins: key regulators of cellular functions
Silacci P., Mazzolai L., Gauci C., Stergiopulos N., Yin H. L., Hayoz D., 2004/10. Cellular and Molecular Life Sciences, 61 (19-20) pp. 2614-23.
[DOI][WoS][Pmid][serval:BIB_C706E7A84592]
 
Comparative assessment of intimal hyperplasia development after 14 days in two different experimental settings: tissue culture versus ex vivo continuous perfusion of human saphenous vein.
Rey J., Probst H., Mazzolai L., Bosman F.T., Pusztaszeri M., Stergiopulos N., Ris H.B., Hayoz D., Saucy F., Corpataux J.M., 2004. Journal of Surgical Research, 121 (1) pp. 42-49. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_9FA5D5280CFA]
 
Endogenous angiotensin II induces atherosclerotic plaque vulnerability and elicits a Th1 response in ApoE-/- mice.
Mazzolai L., Duchosal M.A., Korber M., Bouzourene K., Aubert J.F., Hao H., Vallet V., Brunner H.R., Nussberger J., Gabbiani G. et al., 2004. Hypertension, 44 (3) pp. 277-82.
[DOI][WoS][Pmid][serval:BIB_D7D0DDC27C95]
2003
Blood sampling methodology is crucial for precise measurement of plasma catecholamines concentrations in mice.
Grouzmann E., Cavadas C., Grand D., Moratel M., Aubert J.F., Brunner H.R., Mazzolai L., 2003. Pflügers Archiv, 447 (2) pp. 254-258. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_CD6361A9EDD6]
 
Candida albicans: a rare cause of extracranial carotid artery mycotic pseudo-aneurysm.
Ducrey N., Ruchat P., Teta D., Hayoz D., Mazzolai L., 2003. European Journal of Vascular and Endovascular Surgery Extra, 6 (6) pp. 107-109. Peer-reviewed.
[DOI][serval:BIB_8108B5D2DED8]
 
ET-1 and NOS III gene expression regulation by plaque-free and plaque-prone hemodynamic conditions
Mattart M., Mazzolai L., Chambaz C., Hayoz D., Brunner H. R., Silacci P., 2003. Biorheology, 40 (1-3) pp. 289-97.
[WoS][Pmid][serval:BIB_4303A4D417A5]
2002
 
Tissue factor activity is upregulated in human endothelial cells exposed to oscillatory shear stress
Mazzolai L., Silacci P., Bouzourene K., Daniel F., Brunner H., Hayoz D., 2002/06. Thrombosis and Haemostasis, 87 (6) pp. 1062-8.
[WoS][Pmid][serval:BIB_791ECC5B2E39]
 
D-dimers testing is not recommended for the exclusion of deep vein thrombosis in outpatients with lower limb erysipelas.
Mazzolai L., Haesler E., Milesi I., Hayoz D., 2002. Thrombosis and haemostasis, 88 (5) p. 880. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_D6FDAD428FCE]
 
Echo-Doppler vasculaire et fistules d'hémodialyse
41. Haesler E., Milesi I., Mazzolai L., Hayoz D. , 2002. Kardiovasculäre Medizin, 5 pp. 317-329.
[serval:BIB_724724543258]
2001
 
Flow pulsatility is a critical determinant of oxidative stress in endothelial cells
Silacci P., Desgeorges A., Mazzolai L., Chambaz C., Hayoz D., 2001/11. Hypertension, 38 (5) pp. 1162-6.
[DOI][WoS][Pmid][serval:BIB_BF01C005F0AA]
 
Angiotensin II receptor antagonists: safety and tolerability profile.
Mazzolai L., Burnier M., 2001. pp. 339-350 dans Epstein M., Brunner H.R. (eds.) Angiotensin II Receptor Antagonists, Hanley & Belfus.
[serval:BIB_81F12D2B5F4D]
2000
 
Increased cardiac angiotensin II levels induce right and left ventricular hypertrophy in normotensive mice.
Mazzolai L., Pedrazzini T., Nicoud F., Gabbiani G., Brunner H.R., Nussberger J., 2000. Hypertension, 35 (4) pp. 985-91. Peer-reviewed.
[WoS][Pmid][serval:BIB_4FE360B42251]
1999
 
Comparative safety and tolerability of angiotensin II receptor antagonists
Mazzolai L., Burnier M., 1999/07. Drug Safety, 21 (1) pp. 23-33.
[DOI][WoS][Pmid][serval:BIB_E5A1DB4B97E2]
 
Angiotensin II can mediate cardiac hypertrophy independently from blood pressure changes
Mazzolai L, 1999. Kardiovasculäre Medizin, 2 pp. 235-237.
[serval:BIB_C98B5486EAFD]
 
Angiotensin II receptor blockade in normotensive subjects: A direct comparison of three AT1 receptor antagonists.
Mazzolai L., Maillard M., Rossat J., Nussberger J., Brunner H.R., Burnier M., 1999. Hypertension, 33 (3) pp. 850-5. Peer-reviewed.
[WoS][Pmid][serval:BIB_7A8B77785129]
Assessment of angiotensin II receptor blockade in humans using a standardized angiotensin II receptor-binding assay.
Maillard M.P., Mazzolai L., Daven V., Centeno C., Nussberger J., Brunner H.R., Burnier M., 1999. American journal of hypertension, 12 (12 Pt 1-2) pp. 1201-8. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_5EE756EA6CCB]
 
Les inhibiteurs de l'enzyme de conversion de l'angiotensine
40. Burnier M. Mazzolai L., 1999. Cardioscopie, 72 (270).
[serval:BIB_F4D8F4CC7798]
1998
 
Blood pressure-independent cardiac hypertrophy induced by locally activated renin-angiotensin system.
Mazzolai L., Nussberger J., Aubert J.F., Brunner D.B., Gabbiani G., Brunner H.R., Pedrazzini T., 1998. Hypertension, 31 (6) pp. 1324-30. Peer-reviewed.
[WoS][Pmid][serval:BIB_EA30D8FD2ECD]
1997
 
Two-kidney, one clip and one-kidney, one clip hypertension in mice.
Wiesel P., Mazzolai L., Nussberger J., Pedrazzini T., 1997. Hypertension, 29 (4) pp. 1025-30. Peer-reviewed.
[WoS][Pmid][serval:BIB_DB833FA5D872]
1994
 
La Meta analisi degli studi clinici sulla prevenzione delle TVP
Agnelli G. Mazzolai L.. (eds.), 1994., Atti della Riunione Satellite: Meta analisi in medicina, aspetti statistici ed implicazioni cliniche..
[serval:BIB_83B5BD3BC318]
 
Plasma thrombin neutralization assay: pharmacokinetic applications.
Iorio A., Alatri A., Mazzolai L., Agnelli G., 1994. Seminars In Thrombosis and Hemostasis, 20 (3) pp. 266-273.
[DOI][WoS][Pmid][serval:BIB_0815FE106026]
1992
 
Subcutaneous heparin compared with continuous intravenous heparin administration in the initial treatment of deep vein thrombosis. A meta-analysis
Hommes D. W., Bura A., Mazzolai L., Buller H. R., ten Cate J. W., 1992/02. Annals of Internal Medicine, 116 (4) pp. 279-84.
[WoS][Pmid][serval:BIB_AAA09652EF8B]
Partagez:
Unicentre - CH-1015 Lausanne
Suisse
Tél. +41 21 692 11 11
Canton de Vaud
Swiss University